Elevated levels of complement-related markers such as von Willebrand factor, thrombomodulin, and angiopoietin-2 are frequently observed in patients with severe COVID-19, underscoring the link between complement activation, endothelial dysfunction, and thrombotic complications (34, 35). This evidence concerns the gene THBD and endothelial dysfunction.